"Immuni" and the National Health System: Lessons Learnt from the COVID-19 Digital Contact Tracing in Italy.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
20 06 2022
Historique:
received: 27 04 2022
revised: 07 06 2022
accepted: 09 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Since the early stage of the current pandemic, digital contact tracing (DCT) through mobile phone apps, called "Immuni", has been introduced to complement manual contact tracing in Italy. Until 31 December 2021, Immuni identified 44,880 COVID-19 cases, which corresponds to less than 1% of total COVID-19 cases reported in Italy in the same period (5,886,411). Overall, Immuni generated 143,956 notifications. Although the initial download of the Immuni app represented an early interest in the new tool, Immuni has had little adoption across the Italian population, and the recent increase in its download is likely to be related to the mandatory Green Pass certification for conducting most daily activities that can be obtained via the application. Therefore, Immuni failed as a support tool for the contact tracing system. Other European experiences seem to show similar limitations in the use of DTC, leaving open questions about its effectiveness, although in theory, contact tracing could allow useful means of "proximity tracking".

Identifiants

pubmed: 35742778
pii: ijerph19127529
doi: 10.3390/ijerph19127529
pmc: PMC9223529
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Swiss Med Wkly. 2021 Sep 08;151(35-36):
pubmed: 34495624
Nature. 2021 Jun;594(7863):408-412
pubmed: 33979832
Science. 2020 May 8;368(6491):
pubmed: 32234805
Lancet Digit Health. 2020 Nov;2(11):e607-e621
pubmed: 32839755
Front Digit Health. 2021 Jun 17;3:660823
pubmed: 34713135
J Med Internet Res. 2021 Mar 2;23(3):e23362
pubmed: 33577466
Int J Environ Res Public Health. 2021 Oct 06;18(19):
pubmed: 34639796
Lancet Public Health. 2020 May;5(5):e253
pubmed: 32220653
Lancet Public Health. 2022 Mar;7(3):e206-e207
pubmed: 35131044
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2449-2456
pubmed: 33755984
Nat Commun. 2021 Jan 26;12(1):587
pubmed: 33500407
JMIR Form Res. 2021 Mar 26;5(3):e27882
pubmed: 33724198
Nat Med. 2021 Mar;27(3):361-362
pubmed: 33589822
JMIR Public Health Surveill. 2020 Sep 1;6(3):e20572
pubmed: 32755882

Auteurs

Silvia Ussai (S)

Clinical Pharmacology and Toxicology, University of Cagliari, 09124 Cagliari, Italy.

Marco Pistis (M)

Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, 09124 Cagliari, Italy.

Eduardo Missoni (E)

Center for Research on Health and Social Care Management (CERGAS), Bocconi University, 20124 Milan, Italy.
Saluteglobale.it Associazione di Promozione Sociale, 25123 Brescia, Italy.

Beatrice Formenti (B)

Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.

Benedetta Armocida (B)

Istituto Superiore di Sanità, Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, 00161 Rome, Italy.

Tatiana Pedrazzi (T)

Department of Occupational Medicine, Hygiene, Toxicology and Occupational Prevention, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.

Francesco Castelli (F)

Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.

Lorenzo Monasta (L)

Clinical Epidemiology and Public Health Research Unit, Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Trieste, Italy.

Baldassare Lauria (B)

G. Gulotta" Foundation, 50100 Florence, Italy.

Ilaria Mariani (I)

WHO Collaborating Centre, Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", 34137 Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH